Establishment of an in vivo model facilitates B2 receptorprotein maturation and heterodimerization
Abstract
In individuals with diverse cardiovascular risk factors,
Maintenance work is planned from 21:00 BST on Tuesday 20th August 2024 to 21:00 BST on Wednesday 21st August 2024, and on Thursday 29th August 2024 from 11:00 to 12:00 BST.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to log in or to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Molecular Pharmacology Unit, Swiss Federal Institute of Technology and University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
E-mail:
ursula.quitterer@pharma.ethz.ch
Fax: +41 44 635 6881
b Department of Clinical Chemistry/Central Laboratories, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
In individuals with diverse cardiovascular risk factors,
Fetching data from CrossRef.
This may take some time to load.
Loading related content